IsoTherapeutics Group LLC

Company Information
Address 1004 S. Velasco
Angleton, TX, 77515-5250


Information

DUNS: 621139976

# of Employees: 14


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. High Specific Activity Sn-117m by Post Irradiation Isotope Separation

    Amount: $149,800.00

    The radioisotope tin-117m (117mSn) is a theranostic isotope that is suitable for both diagnostic and therapeutic applications. Its low energy gamma rays can be imaged using standard gamma cameras. F ...

    SBIRPhase I2014Department of Energy
  2. A new radiopharmaceutical for the treatment of metastatic bone cancer

    Amount: $1,396,558.00

    DESCRIPTION (provided by applicant): There are roughly 250,000 new cases of metastatic cancer to the skeleton in the U.S. each year. Bone-seeking radiopharmaceuticals are used for bone pain palliati ...

    SBIRPhase II2013Department of Health and Human Services
  3. A new radiopharmaceutical for the treatment of metastatic bone cancer

    Amount: $1,490,797.00

    DESCRIPTION provided by applicant There are roughly new cases of metastatic cancer to the skeleton in the U S each year andquot Bone seekingandquot radiopharmaceuticals are used for bone ...

    SBIRPhase II2013Department of Health and Human Services National Institutes of Health
  4. High Specific Activity Sm-153 by Post Irradiation Isotope Separation

    Amount: $989,748.00

    Samarium-153 (153Sm) has ideal nuclear properties for a variety of therapeutic applications; however, it is only available in low specific activity (radioactivity/weight) form. While large quantitie ...

    SBIRPhase II2012Department of Energy
  5. High Specific Activity Sm-153 by Post Irradiation Isotope Separation

    Amount: $149,476.00

    When the stable samarium-152 (Sm-152) isotope is irradiated, radioactive samarium-153 (Sm-153) is produced through a neutron capture reaction in yields of only about 2%, and this radioactive, therapeu ...

    SBIRPhase I2011Department of Energy
  6. A new radiopharmaceutical for the treatment of metastatic bone cancer

    Amount: $143,582.00

    DESCRIPTION (provided by applicant): Bone-seeking radiopharmaceuticals are used extensively for bone pain palliation and have shown promise for treating bone metastases. They typically combine a rad ...

    SBIRPhase I2010Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government